Compound ID | 2311
Class: Glycopeptide
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Escherichia coli, Acinetobacter baumannii, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa |
| Description: | Synthetic compound; vancomycin analogue; selective activity towards Gram-positives |
| Year first mentioned: | 2016 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|